NASDAQ: ZY - Zymergen Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Zymergen Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Zymergen Inc.

Zymergen Inc. разрабатывает, проектирует и оптимизирует микробы для промышленного применения в США, Азии и Европе. У компании есть платформа, которая рассматривает геном как пространство поиска для выявления генетических изменений, которые улучшают экономику био-продуктов ее клиентов для ряда отраслей, включая химическую промышленность и материалы, сельское хозяйство и фармацевтику. Платформа Zymergen используется для открытия новых молекул, обеспечивающих уникальные свойства материалов. Компания была зарегистрирована в 2013 году и базируется в Эмеривилле, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-04-22
ISIN US98985X1000
Industry Chemicals
Sector Materials
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.zymergen.com
Цена ао 2.43
Change price per day: 0% (2.43)
Change price per week: 0% (2.43)
Change price per month: 0% (2.43)
Change price per 3 month: 0% (2.43)
Change price per half year: 0% (2.43)
Change price per year: 0% (2.43)
Change price per 3 year: -19.8% (3.03)
Change price per 5 year: 0% (2.43)
Change price per 10 year: 0% (2.43)
Change price per year to date: 0% (2.43)
All parameters

Underestimation

Title Value Grade
P/S 17.74 1
P/BV 1.07 9
P/E 0 0
EV/EBITDA 0.0868 10
Total: 5

Efficiency

Title Value Grade
ROA, % -73.48 0
ROE, % -113.14 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.5876 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % -2.67 0
Yield Ebitda, % 12.32 2
Yield EPS, % 49.17 6
Total: 4
More

Institutions Volume Share, %
SB INVESTMENT ADVISERS (UK) LTD 26614219 25.99
ARK Investment Management LLC 5004359 4.89
Perceptive Advisors LLC 3266664 3.19
BAMCO Inc 2666218 2.6
Baron Capital Management Inc 1994904 1.95
Redmile Group, LLC 1522900 1.49
J.P. Morgan Investment Management, Inc. 1295413 1.27
JPMorgan Asset Management (Europe) S.à r.l. 1203876 1.18
ICONIQ Capital, LLC 990765 0.97
Cota Capital Management, LLC 989388 0.97
Janus Henderson Investors 874696 0.85
Comprehensive Financial Management LLC 769321 0.75
Morgan Stanley Investment Management, Inc. 601110 0.59
Tao Capital Management LP 247690 0.24
PURA VIDA INVESTMENTS, LLC 214577 0.21
Lincoln Investment Advisors Corporation 195825 0.19
Goldman Sachs Asset Management, L.P. 176640 0.17
Equitable 142597 0.14
Voya Investments, LLC 134436 0.13
The Variable Annuity Life Insurance Company 113501 0.11
JP Morgan Asset Management (UK) Ltd 94498 0.09
Putnam Investment Management, LLC 83576 0.08
JPMorgan Chase Bank 67724 0.07
Bill & Melinda Gates Foundation 59970 0.06
OFI LUX 20269 0.02
Emerge Canada Inc. 16080 0.02
Putnam 5849 0.01
Envestnet Asset Management Inc 227 0
Baillie Gifford Overseas Limited 0 0



Head Job title Payment Year of birth
Ms. Enakshi Singh Chief Financial Officer 390.3k 1978 (47 years)
Ms. Mina Kim Corp. Sec. N/A 1974 (51 year)
Mike Dulin Director of Communications N/A
Mr. Lincoln Germain Chief Commercial Officer N/A
Mr. Subodh S. Deshmukh Chief Devel. Officer N/A
Mr. Dmitriy Ryaboy Chief Technology Officer N/A
Mr. Devin Scannell Sr. VP of Drug Discovery N/A
Mr. Duane Valz J.D. Sec. N/A

Address: United States, EmeryVille, CA , 5980 Horton Street - open in Google maps, open in Yandex maps
Website: http://www.zymergen.com